期刊名：Antibodies

期刊主页：https://www.mdpi.com/journal/antibodies

本期编辑荐读为您精选2024年发表于 Antibodies 期刊的十篇热门综述。希望能为相关领域学者提供新的思路和参考，欢迎阅读。

1. Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature

抗磷脂抗体与血液透析患者自体动静脉瘘并发症的关系：文献综述

https://www.mdpi.com/2073-4468/13/1/1

Taghavi, M.; Jabrane, A.; Jacobs, L.; Mesquita, M.D.C.F.; Demulder, A.; Nortier, J. Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature. Antibodies 2024, 13, 1.

2. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies

免疫介导性坏死性肌病（IMNM）：抗体的故事

https://www.mdpi.com/2073-4468/13/1/12

Julien, S.; Challier, I.; Malleter, M.; Jouen, F.; Drouot, L.; Boyer, O. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies. Antibodies 2024, 13, 12.

3. SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination

SARS-CoV-2：感染和疫苗接种引发的先天免疫反应概览

https://www.mdpi.com/2073-4468/13/1/13

Manfrini, N.; Notarbartolo, S.; Grifantini, R.; Pesce, E. SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination. Antibodies 2024, 13, 13.

4. Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

灾难性抗磷脂综合征的诊断和治疗以及2023年ACR/EULAR抗磷脂综合征分类标准的潜在影响

https://www.mdpi.com/2073-4468/13/1/21

Jacobs, L.; Wauters, N.; Lablad, Y.; Morelle, J.; Taghavi, M. Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Antibodies 2024, 13, 21.

5. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes

影响1型糖尿病中B细胞识别自身抗原和功能的因素

https://www.mdpi.com/2073-4468/13/2/27

Bass, L.E.; Bonami, R.H. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes. Antibodies 2024, 13, 27.

6. Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management

髓鞘少突胶质细胞糖蛋白抗体相关疾病：临床表现、发病机制和治疗管理的最新综述

https://www.mdpi.com/2073-4468/13/2/43

Gklinos, P.; Dobson, R. Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management. Antibodies 2024, 13, 43.

7. Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer

靶向癌症新抗原：乳腺癌治疗的可能性和机遇

https://www.mdpi.com/2073-4468/13/2/46

Chaudhry, Z.; Boyadzhyan, A.; Sasaninia, K.; Rai, V. Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer. Antibodies 2024, 13, 46.

8. A Comparison of Natural and Therapeutic Anti-IgE Antibodies

天然抗IgE抗体与治疗性抗IgE抗体的比较

https://www.mdpi.com/2073-4468/13/3/58

Vogel, M.; Engeroff, P. A Comparison of Natural and Therapeutic Anti-IgE Antibodies. Antibodies 2024, 13, 58.

9. Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules

银屑病治疗进展：从生物制剂到新兴口服小分子药物

https://www.mdpi.com/2073-4468/13/3/76

Ferrara, F.; Verduci, C.; Laconi, E.; Mangione, A.; Dondi, C.; Del Vecchio, M.; Carlevatti, V.; Zovi, A.; Capuozzo, M.; Langella, R. Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules. Antibodies 2024, 13, 76.

10. Unveiling GFAP Astrocytopathy: Insights from Case Studies and a Comprehensive Review of the Literature

揭示GFAP星形胶质细胞病：病例研究的启示和文献综述

https://www.mdpi.com/2073-4468/13/4/79

Gklinos, P.; Athanasopoulos, F.; Giatrakou, V.; Arkoudis, N.-A.; Pournara, D.; Giagkou, E.; Tountopoulou, A.; Vassilopoulou, S.; Mitsikostas, D.-D. Unveiling GFAP Astrocytopathy: Insights from Case Studies and a Comprehensive Review of the Literature. Antibodies 2024, 13, 79.